The effects of tobacco smoke on the homocysteine level - A risk factor of atherosclerosis

Addiction Biology

Volumn 8, Issue 2, 2003, Pages 147-158

  Sobczak, Andrzej ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; HOMOCYSTEINE; PYRIDOXINE; TOBACCO SMOKE;

AMINO ACID BLOOD LEVEL; AMINO ACID METABOLISM; ATHEROGENESIS; ATHEROSCLEROSIS; CEREBROVASCULAR DISEASE; CIGARETTE SMOKING; COHORT ANALYSIS; CORONARY ARTERY DISEASE; CORONARY RISK; HUMAN; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; THROMBOGENESIS;

CORONARY ARTERIOSCLEROSIS; FOLIC ACID DEFICIENCY; HOMOCYSTEINE; HUMANS; INTRACRANIAL ARTERIOSCLEROSIS; PERIPHERAL VASCULAR DISEASES; RISK FACTORS; TOBACCO USE DISORDER; VITAMIN B 12 DEFICIENCY; VITAMIN B 6 DEFICIENCY;

EID: 0038148115     PISSN: 13556215     EISSN: None     Source Type: Journal    
DOI: 10.1080/13556210310001117374     Document Type: Review

References (76)

1. World Bank. Development in practice - curbing the epidemic: governments and the economics of tobacco control. Washington DC: World Bank, 1999; pp. 32-3.
2. Murray CJL, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study. Lancet 1997;349:1498-504.
3. Silverstein P. Smoking and wound healing. Am J Med 1992;93(Suppl 1A):S22-4.
4. Pittilo RM. Cigarette smoking, endothelial injury and cardiovascular disease. Int J Exp Patrol 2000;81:219-30.
5. Church DF, Pryor WA. Free radical chemistry of cigarette smoke and its toxicological implications. Environ Health Persp 1985;64:111-26.
6. Pryor WA, Church DF, Evans MD, Rice WY, Hayes JR. A comparison of the free radical chemistry of tobacco burning cigarettes that only heat tobacco. Free Radic Biol Med 1990;8:275-9.
7. Zang LY, Stone K, Pryror WA. Detection of free radicals in aqueous extracts of cigarette tar by electron-spin resonance. Free Radic Biol Med 1995;19:161-7.
8. Benowitz NL, Gourlay SG. Cardiovascular toxicity of nicotine: implications for nicotine replacement therapy. J Am Coll Cardiol 1997;29:1422-31.
9. Ueland PM, Refsum H, Beresford SA, Vollset SE. The controversy over homocysteine and cardiovascular risk. Am J Clin Nutr 2000;72:324-32.
10. Ueland PM. Homocysteine species as components of plasma redox thiol status. Clin Chem 1995;41:340-2.
11. Mansoor MA, Svardal AM, Ueland PM. Determination of the in vivo redox status of cysteine, cysteinylglycine, homocysteine, and glutathione in human plasma. Anal Biochem 1992;200:218-29.
12. Mudd SH, Finkelstein JD, Refsum H, et al. Homocysteine and its disulphide derivatives: a suggested consensus terminology. Arterioscler Thromb Vasc Biol 2000;20:1704-6.
13. Larkin M, Kilmer McCully: pioneer of the homocysteine theory. Lancet 1998;352:1364-65.
14. Naruszewicz M, Mirkiewicz E, Olszewski AJ, McCully KS. Thiolation of low-density lipoprotein by homocysteine thiolactone causes increased aggregation and altered interaction with cultured macrophages. Nutrit Metab Cardiovasc Dis 1994;4:70-7.
15. Stary HC, Chandler AB, Glagov S, et al. Special report: a definition of initial, fatty streak, and intermediate lesions of atherosclerosis: a report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Circulation 1994;98:2462-78.
16. Naruszewicz M, Klinke M, Bukowska H, Bobnis M. Elevated homocyst(e)ine increased ability of human aortic cells to oxide LDL. Atherosclerosis 1997;134:13-14.
17. Duan J, Murohara T, Ikeda H, et al. Hyperhomocysteinemia impairs angiogenesis in response to hindlimb ischemia. Arterioscler Thromb Vasc Biol 2000;20:2579-85.
18. Nagai Y, Tasaki H, Miyamoto M, et al. Plasma level of homocysteine is inversely-associated with the development of collateral circulation in patients with single-vessel coronary artery disease. Circ J 2002;66:158-62.
19. Blann AD. Endothelial cell damage and homocysteine. Atherosclerosis 1992;94:89-91.
20. Fryer RH, Wilson BD, Gubler DB, Fitzgerald LA, Rodgers GM. Homocysteine, a risk factor for premature vascular disease and thrombosis, induces tissue factor activity in endothelial cells. Arterioscler Thromb 1993;13:1327-33.
21. Salonen JT, Nyyssonen K, Salonen R, et al. Lipoprotein oxidation and progression of carotid atherosclerosis. Circulation 1997;95:840-5.
22. Rowley DA, Halliwell B. Superoxide-dependent formation of hydroxyl radicals in the presence of thiol compounds. FEBS Lett 1982;138:33-6.
23. Domagała TB, Libura M, Szczeklik A. Hyperhomocysteinemia following oral methionine load is associated with lipid peroxidation. Thromb Res 1997;87:411-16.
24. Hernanz A, Fernandez-Vivancos E, Montiel C, Vazquez JJ, Arnalich F. Changes in the intracellular homocysteine and glutathione content associated with aging. Life Sci 2000;67:1317-24.
25. Voutilainen S, Morrow JD, Roberts LJ II, et al. Enhanced in vivo lipid peroxidation at elevated plasma total homocysteine levels. Arterioscler Thromb Vasc Biol 1999;19:1263-66.
26. 2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci USA 1990;87:9383-7.
27. 2-isoprostanes, are present in increased amounts in human atherosclerotic lesions. Arteriscler Thromb Vasc Biol 1997;17:3236-41.
28. Mehrabi MR, Ekmekcioglu C, Tatzber F, et al. The isoprostane, 8-epi-PGF2 alpha, is accumulated in coronary arteries isolated from patients with coronary heart disease. Cardiovasc Res 1999;43:492-9.
29. 2-isoprostanes in human atherosclerotic lesion. J Clin Invest 1997;100:2028-34.
30. Hofmann MA, Lalla E, Lu Y, et al. Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in murine model. J Clin Invest 2001;107:675-83.
31. Zhou J, Moller J, Danieson CC, et al. Hyperhomocysteinemia promotes the development of collagen-rich and stable plaques in apoE-deficient mice. Arterioscler Thromb Vasc Biol 2001;21:1470-6.
32. International Task Force for Prevention of Coronary Heart Disease Coronary Heart Disease. Reducing the risk: the scientific background for primary and secondary prevention of heart disease. A worldwide view. Nutr Metab Cardiovasc Dis 199838:205-71.
33. Nygard O, Noedrehaug JE, Refsum H, Ueland PM, Farstad M, Vollset SE. Plasma homocysteine levels and morality in patients with coronary artery disease. N Engl J Med 1997;337:230-6.
34. Nygard O, Refsum H, Ueland PM, Vollset SE. Major life style determinants of plasma total homocysteine distribution: the Hordaland Homocysteine Study. Am J Clin Nutr 1998;67:263-70.
35. Finkelstein JD. Metionine metabolism in mammals. J Nutr Biochem 1990;1:228-37.
36. McKeever MP, Weir DG, Molly A, Scott JM. Betaine-homocysteine methyltransferase: organ distribution in man, pig, rat and subcellular distribution in the rat. Clin Sci 1991;81:551-6.
37. Clarke R. An overview of the homocysteine lowering clinical trials. In: Robinson K, editor. Homocysteine and vascular disease. Dordrecht: Kluwer Academic, 2000; pp. 413-29.
38. Homocysteine Lowering Trialists' Collaboration. Lowering blood homocysteine with folic acid based supplements: Meta-analysis of randomized trials. Br Med J 1998;316:894-8.
39. Brouwer IA, van Dusseldrop M, Thomas CMG, et al. Low-dose folic acid supplementation decreases plasma homocysteine concentrations: a randomized trial. Am J Clin Nutr 1999;69:99-104.
40. Brouwer IA, van Dusseldrop M, West CE, et al. Dietary folate from vegetables and citrus fruit decreases plasma homocysteine concentrations in humans in a dietary controlled trial. J Nutr 1999;129:1135-9.
41. Selhub J, Jacques PF, Bostom AG, Wilson PW, Rosenberg IH. Relationship between plasma homocysteine and vitamin status in the Framingham study population Impact of folic acid fortification. Public Health Rev 2000;28:117-45.
42. Voutilainen S, Rissanen T, Lakka TA, Salonen JT. Low dietary intake is associated with an excess incidence of acute coronary events: the Kuopio Ischaemic Heart Disease Risk Factor (KIHD) Study. Circulation 2001;103:2674-80.
43. Serfontein WJ, Ubbink JB, DeVilliers LS, Becker PJ. Depressed plasma pyridoxal-5′-phosphate levels in tobacco-smoking men. Atherosclerosis 1986;59:341-6.
44. Vermaak WJH, Ubbink JB, Barnard HC, Potgieter GM, van Jaarsveld H, Groenewald AJ. Vitamin B-6 nutrition status and cigarette smoking. Am J Clin Nutr 1990;51:1058-61.
45. Piyathilake CJ, Macaluso M, Hine RJ, Richards EW, Krumdieck CL. Local and systemic effects of cigarette smoking on folate and vitamin B-12. Am J Clin Nutr 1994;60:559-66.
46. Giraud DW, Martin HD, Driskell JA. Erythrocyte and plasma B-6 vitamin concentrations of long-term tobacco smokers, chewers, and nonusers. Am J Clin Nutr 1995;62:104-9.
47. Mansoor MA, Kristensen O, Hervig T, et al. Low concentrations of folate in serum and erythrocytes of smokers: methionine loading decreases folate concentrations in serum of smokers and nonsmokers. Clin Chem 1997;43:2192-4.
48. Pagan K, Hou J, Goldenberg RL, Cliver SP, Tamura T. Effect of smoking on serum concentrations of total homocystine and B vitamins in midpregnancy. Clin Chem Acta 2001;306:103-9.
49. Dekou V, Gudnason V, Hawe E, Miller GJ, Stansbie D, Humphries SE. Gene-environment and gene-gene interaction in the determination of plasma homocysteine levels in healthy middle-aged men. Thromb Haemos 2001;85:67-74.
50. Subar AF, Harlan LC, Mattson ME. Food and nutrition intake differences between smokers and nonsmokers in the US. Am J Public Health 1990;80:1323-9.
51. Linnell JC, Smith CL, Wilson J, Matthews DM. Effects of smoking on metabolism and excretion of vitamin B-12. Br Med J 1986;2:215-16.
52. Kondo H, Osborne M.L, Kolhouse JF, et al. Nitrous oxide has multiple deleterious effects on cobalamin metabolism and causes decreases in activities of both mammalian cobalamin-dependent enzymes in rats. J Clin Invest 1981;67:1270-83.
53. Frasca V, Riazzi BS, Matthews RG. In vitro inactivation of metionine synthase by nitrous oxide. J Biol Chem 1986;261:15823-6.
54. McCarty MF. Increased homocyst(e)ine associated with smoking, chronic inflammation, and aging may reflect acute-phase induction of pyridoxal phosphatase activity. Med Hypoth 2000;55:289-93.
55. Bergmark C, Mansoor MA, Svardal A, deFaire U. Redox status of plasma homocysteine and related aminothiols in smoking and nonsmoking young adults. Clinical Chem 1997;43:1997-9.
56. Soriani M, Pietraforte D, Minetti M. Antioxidant potential of anaerobic human plasma: role of serum albumin and thiols as scavengers of carbon radicals. Arch Biochem Biophys 1994;312:180-8.
57. Nygard O, Vollset SE, Refsum H, et al. Total plasma homocysteine and cardiovascular risk profile: the Hordaland Homocysteine Stady. JAMA 1995;274:1526-33.
58. Perry IJ, Refsum H, Morris RW, Ebrahim SB, Ueland PM, Shaper AG. Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Lancet 1995;346:1395-8.
59. Nygard O, Refsum H, Ueland PM, et al. Coffee consumption and plasma total homocysteine: the Hordaland Homocysteine Study. Am J Clin Nutr 1997;65:136-43.
60. Kittner SJ, Giles WH, Macko RF, et al. Homocyst(e)ine and risk of cerebral infraction in a biracial population: the Stroke Prevention in Young Women Study. Stroke 1999;30:1554-60.
61. Whincup PH, Refsum H, Perry IJ, et al. Serum total homocysteine and coronary heart disease: prospective study in middle aged men. Heart 1999;82:448-54.
62. Targher G, Bertolini L, Zenari L, et al. Cigarette smoking and plasma total homocysteine levels in young adults with type 1 diabetes. Diabetes Care 2000;23:524-8.
63. Saw SM, Yuan JM, Ong CN, et al. Genetic, dietary, and other lifestyle determinants of plasma homocysteine concentrations in middle-aged and older Chinese men and women in Singapore. Am J Clin Nutr 2001;73:232-9.
64. Wallock LM, Tamura T, Mayr CA, Johnston KE, Ames BN, Jacob RA. Low seminal plasma folate concentrations are associated with low sperm density and count in male smokers and nonsmokers. Feril Steril 2001;75:252-9.
65. Jacques PF, Bostom AG, Wilson PWF, Rich S, Rosenberg IH, Selhub J. Determinants of plasma total homocysteine concentration in the Framingham Offspring cohort. Am J Clin Nutr 2001;73:613-21.
66. Osganian SK, Stampfer MJ, Spigelman D, et al. Distribution of factors associated with serum homocysteine levels in children: Child and Adolescent Trial for Cardiovascular Health. JAMA 1999;281:1189-96.
67. de Bree A, Verschuren WMM, Blom HJ, Kromhout D. Association between B vitamin intake and plasma homocysteine concentration in the general Dutch population aged 20-65 years. Am J Clin Nutr 2001;73:1027-33.
68. Haufroid V, Lison D. Urinary cotinine as a tobacco-smoke exposure index: a minireview. Int Arch Occup Environ Health 1998;71:162-8.
69. Petitti DB, Friedman GD, Khan W. Accuracy of information on smoking habits provided on self-administered research questionnaires. Am J Public Health 1981;71:308-11.
70. Stepney R. Are smokers' self-reports of inhalation a useful measure of smoke exposure? J Epidemiol Commun Health 1982;36:109-12.
71. Woodward M, Moohan M, Tunstall-Pedoe H. Self-reported smoking, cigarette yields and inhalation biochemistry related to the incidence of coronary heart disease: results from the Scottish Heart Health Study. J Epidemiol Biostat 1999;4:285-95.
72. Sobczak A, Wardas W, Zielińska-Danch W, Nowak J. Effect of cigarette smoking on plasma homocysteine concentration (in Polish). Czynniki Ryzyka 2001;33/34:54-55.
73. Voutilainen S, Lakka TA, Hamelahti P, Lehtimaki T, Poulsen HE, Salonen JT. Plasma total homocysteine concentration and risk of acute coronary events: the Kuopio Ischaemic Heart Disease Risk Factor Study. J Intern Med 2000;248:217-22.
74. Evans RW, Shaten BJ, Hempel JD, Cutler JA, Kuller LH. Homocyst(e)ine and risk of cardiovascular disease in the Multiple Risk Factor Intervention Trial. Arterioscler Thromb Vasc Biol 1997;17:1947-53.
75. Graham IM, Daly LE, Refsum HM, et al. Plasma homocysteine as a risk factor for vascular disease: the European Concerted Action Project. JAMA 1997;277:1775-81.
76. Nauck M, Bisse E, Nauck M, Wieland H. Preanalytical conditions affecting the determination of plasma homocysteine concentration. Clin Chem Lab Med 2001;39:675-80.